Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

CRISPR01:59

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced Short...
Fertilization01:38

Fertilization

During fertilization, an egg and sperm cell fuse to create a new diploid structure. In humans, the process occurs once the egg has been released from the ovary, and travels into the fallopian tubes. The process requires several key steps: 1) sperm present in the genital tract must locate the egg; 2) once there, sperm need to release enzymes to help them burrow through the protective zona pellucida of the egg; and 3) the membranes of a single sperm cell and egg must fuse, with the sperm...
Transgenic Organisms00:53

Transgenic Organisms

Overview
In-vitro Mutagenesis01:16

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
Spermatogenesis01:41

Spermatogenesis

Spermatogenesis is the process by which haploid sperm cells are produced in the male testes. It starts with stem cells located close to the outer rim of seminiferous tubules. These spermatogonial stem cells divide asymmetrically to give rise to additional stem cells (meaning that these structures “self-renew”), as well as sperm progenitors, called spermatocytes. Importantly, this method of asymmetric mitotic division maintains a population of spermatogonial stem cells in the male reproductive...
What is Genetic Engineering?00:49

What is Genetic Engineering?

Overview

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Presence of PSA antibodies in seminal plasma of infertile men.

Frontiers in bioscience (Elite edition)·2017
Same author

Curcumin: a novel non-steroidal contraceptive with antimicrobial properties.

Frontiers in bioscience (Elite edition)·2015
Same author

Immunocontraception for Animals: Current Status and Future Perspective.

American journal of reproductive immunology (New York, N.Y. : 1989)·2015
Same author

The Effect of Curcumin on Intracellular pH (pHi), Membrane Hyperpolarization and Sperm Motility.

Journal of reproduction & infertility·2014
Same author

Vaccine for human contraception targeting sperm Izumo protein and YLP12 dodecamer peptide.

Protein science : a publication of the Protein Society·2014
Same author

Polycystic ovary syndrome: current status and future perspective.

Frontiers in bioscience (Elite edition)·2014

Related Experiment Video

Updated: Jun 19, 2026

Mouse Round Spermatid Injection
08:41

Mouse Round Spermatid Injection

Published on: January 26, 2024

Development of genetically engineered human sperm immunocontraceptives.

Rajesh K Naz1

  • 1Reproductive Immunology and Molecular Biology Laboratories, Department of Obstetrics and Gynecology, The West Virginia University, School of Medicine, Morgantown, WV 26506-9186, USA. Rnaz@hsc.wvu.edu

Journal of Reproductive Immunology
|October 27, 2009
PubMed
Summary

Developing novel anti-sperm contraceptive vaccines and engineered antibodies offers a promising path toward reversible immunocontraception. These approaches aim to overcome individual immune response variability for effective fertility control.

More Related Videos

Application of Mouse Parthenogenetic Haploid Embryonic Stem Cells as a Substitute of Sperm
08:08

Application of Mouse Parthenogenetic Haploid Embryonic Stem Cells as a Substitute of Sperm

Published on: November 19, 2020

Medium-throughput Screening Assays for Assessment of Effects on Ca2+-Signaling and Acrosome Reaction in Human Sperm
05:44

Medium-throughput Screening Assays for Assessment of Effects on Ca2+-Signaling and Acrosome Reaction in Human Sperm

Published on: March 1, 2019

Related Experiment Videos

Last Updated: Jun 19, 2026

Mouse Round Spermatid Injection
08:41

Mouse Round Spermatid Injection

Published on: January 26, 2024

Application of Mouse Parthenogenetic Haploid Embryonic Stem Cells as a Substitute of Sperm
08:08

Application of Mouse Parthenogenetic Haploid Embryonic Stem Cells as a Substitute of Sperm

Published on: November 19, 2020

Medium-throughput Screening Assays for Assessment of Effects on Ca2+-Signaling and Acrosome Reaction in Human Sperm
05:44

Medium-throughput Screening Assays for Assessment of Effects on Ca2+-Signaling and Acrosome Reaction in Human Sperm

Published on: March 1, 2019

Area of Science:

  • Reproductive immunology
  • Biotechnology
  • Vaccinology

Background:

  • Sperm-targeting contraceptive vaccines are a developing area of reproductive health.
  • Existing methods face challenges due to host immune response variability.

Purpose of the Study:

  • To review anti-sperm contraceptive vaccines and genetically engineered human antibodies for immunocontraception.
  • To explore novel single chain variable fragment (scFv) antibodies and multi-epitope vaccines.

Main Methods:

  • Review of vaccinology and antibody engineering techniques.
  • Synthesis of multi-epitope contraceptive vaccines using sperm antigens, peptide epitopes, or DNA.
  • Development of novel scFv antibodies using phage display technology from immunoinfertile and vasectomized men.

Main Results:

  • Multi-epitope contraceptive vaccines demonstrated reversible contraceptive effects in mouse models.
  • Novel scFv antibodies were synthesized in vitro, reacting with specific sperm antigens.
  • These antibodies inhibit human sperm function in vitro.

Conclusions:

  • Engineered human scFv antibodies show potential as novel, first-in-kind immunocontraceptives for human use.
  • Multi-epitope vaccines and preformed antibodies may mitigate concerns about immune response variability.
  • Further in vivo investigation is needed to confirm the efficacy of these human scFv antibodies.